KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Working Capital Changes (2016 - 2025)

Abbott Laboratories' Other Working Capital Changes history spans 17 years, with the latest figure at $836.0 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 403.61% year-over-year to $836.0 million; the TTM value through Dec 2025 reached $1.3 billion, up 62.69%, while the annual FY2025 figure was $1.3 billion, 62.69% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $836.0 million at Abbott Laboratories, up from -$221.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.1 billion in Q1 2023 and bottomed at -$1.4 billion in Q4 2023.
  • The 5-year median for Other Working Capital Changes is $131.5 million (2021), against an average of $151.0 million.
  • The largest annual shift saw Other Working Capital Changes surged 3316.67% in 2022 before it plummeted 4260.61% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $172.0 million in 2021, then crashed by 80.81% to $33.0 million in 2022, then tumbled by 4260.61% to -$1.4 billion in 2023, then surged by 112.09% to $166.0 million in 2024, then soared by 403.61% to $836.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Other Working Capital Changes are $836.0 million (Q4 2025), -$221.0 million (Q3 2025), and $244.0 million (Q2 2025).